
Rakesh Singh
@rakesh_singh_21
I'm a Business Development Manager at Healthcare News Hubb, where I help our clients grow their business.
ID: 1598191288729247744
01-12-2022 05:44:46
1,1K Tweet
102 Takipçi
1,1K Takip Edilen









JBZ-001 isn’t just another therapy. It’s a scalable, partner-ready platform driving oncology’s next leap. 🌐 Explore: youtu.be/RJPwLI41QAI 📞 Call: 844-748-9474 📅 Book: calendly.com/jabezbio 🔗 Connect: jabezsciences.com #cancerresearch #oncology Jabez Biosciences





Behind every breakthrough is a dream. At Jabez Biosciences, patents safeguard JBZ-001—protecting patients’ hopes and future cancer care. 🔗Watch: youtu.be/RJPwLI41QAI 📞 Call: 844-748-9474 📅Book Now: calendly.com/jabezbio 🌐Explore: jabezsciences.com Jabez Biosciences


At $2/share, NOK Therapeutics is empowering investors to back safer cancer care—where proven survival meets scalable growth 🎥Watch: youtu.be/mK-JjPUXWU4 🌐Explore: noktherapeutics.com 📞Call 844-748-9474 or schedule a call here: calendly.com/noktherapeutics NÖK Therapeutics

At Bivium, the fight against MS & Alzheimer’s is urgent. From 7 attendees to 7M lives breakthroughs must move faster. 📺 Watch → shorturl.at/6FmRB 📅 schedule→ calendly.com/biviumbio/30min 📞 Call the CEO → 1-855-669-3808 📲 Explore → biviumbiosciences.com Bivium Biosciences


JBZ-001 isn’t just a therapy. It’s hope in a capsule—once-daily, potent, scalable—built to give patients more tomorrows. 📺 Explore: youtu.be/RJPwLI41QAI 📅 Book: calendly.com/jabezbio 📞 Call: 844-748-9474 🌐 Connect: jabezsciences.com Jabez Biosciences

From Phase I to IPO: ✅Proven safe ✅6/6 patients alive 11 years after Phase I trial ✅No toxic prep. Faster re-dosing. Immune power restored Watch:youtu.be/mK-JjPUXWU4 Explore:noktherapeutics.com Call:8447489474 Book:calendly.com/noktherapeutics NÖK Therapeutics